A Practical Guide to Treatment of Childhood Absence Epilepsy

被引:83
作者
Kessler, Sudha Kilaru [1 ]
McGinnis, Emily [2 ]
机构
[1] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA
基金
美国国家卫生研究院;
关键词
LONG-TERM PROGNOSIS; VALPROIC ACID; ANTIEPILEPTIC DRUG; LAMOTRIGINE MONOTHERAPY; CHILDREN; SEIZURES; ETHOSUXIMIDE; EEG; PHARMACOKINETICS; LEVETIRACETAM;
D O I
10.1007/s40272-019-00325-x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Childhood absence epilepsy (CAE) is a common pediatric epilepsy syndrome with distinct seizure semiology, electroencephalography (EEG) features, and treatment. A diagnosis of CAE can be obtained during an office visit with a careful history, physical exam including prolonged hyperventilation, and a routine EEG. The treatment of choice for CAE with absence seizures only is ethosuximide. Valproic acid and lamotrigine are also effective treatments for many patients, but when compared to ethosuximide, valproic acid has more adverse effects and lamotrigine is less effective. Attention to predictors of response to treatment, including clinical, electrographic, and genetic factors, is increasing. Refractory CAE occurs in fewer than half of patients, and treatment strategies are available, though efficacy data are lacking. Careful assessment and treatment of psychosocial comorbidities is essential in caring for patients with CAE.
引用
收藏
页码:15 / 24
页数:10
相关论文
共 66 条
[1]   Comparison and predictors of rash associated with 15 antiepileptic drugs [J].
Arif, H. ;
Buchsbaum, R. ;
Weintraub, D. ;
Koyfman, S. ;
Salas-Humara, C. ;
Bazil, C. W. ;
Resor, S. R., Jr. ;
Hirsch, L. J. .
NEUROLOGY, 2007, 68 (20) :1701-1709
[2]   Aggravation of absence seizure related to levetiracetam [J].
Auvin, Stephane ;
Chhun, Stephanie ;
Berquin, Patrick ;
Ponchel, Emilie ;
Delanoe, Catherine ;
Chiron, Catherine .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2011, 15 (06) :508-511
[3]   CLINICAL PHARMACOKINETICS OF ANTIEPILEPTIC DRUGS IN PEDIATRIC-PATIENTS .1. PHENOBARBITAL, PRIMIDONE, VALPROIC ACID, ETHOSUXIMIDE AND MESUXIMIDE [J].
BATTINO, D ;
ESTIENNE, M ;
AVANZINI, G .
CLINICAL PHARMACOKINETICS, 1995, 29 (04) :257-286
[4]   Long-term seizure remission in childhood absence epilepsy: Might initial treatment matter? [J].
Berg, Anne T. ;
Levy, Susan R. ;
Testa, Francine M. ;
Blumenfeld, Hal .
EPILEPSIA, 2014, 55 (04) :551-557
[5]  
BOURGEOIS BFD, 1988, J PHARMACOL EXP THER, V247, P1128
[6]   Lamotrigine substitution study: Evidence for synergism with sodium valproate? [J].
Brodie, MJ ;
Yuen, AWC .
EPILEPSY RESEARCH, 1997, 26 (03) :423-432
[7]  
Buchanan RA, J CLIN PHARM J, V9, P393
[8]  
Buoli M, 2018, DRUGS, V18
[9]   Long-term outcome of childhood absence epilepsy: Dutch Study of Epilepsy in Childhood [J].
Callenbach, Petra M. C. ;
Bouma, Paul A. D. ;
Geerts, Ada T. ;
Arts, Willem Frans M. ;
Stroink, Hans ;
Peeters, Els A. J. ;
van Donselaar, Cees A. ;
Peters, A. C. Boudewijn ;
Brouwer, Oebele F. .
EPILEPSY RESEARCH, 2009, 83 (2-3) :249-256
[10]   ASYMPTOMATIC CHILDREN WITH EPILEPSY - LITTLE BENEFIT FROM SCREENING FOR ANTICONVULSANT-INDUCED LIVER, BLOOD, OR RENAL DAMAGE [J].
CAMFIELD, C ;
CAMFIELD, P ;
SMITH, E ;
TIBBLES, JAR .
NEUROLOGY, 1986, 36 (06) :838-841